Assessment of Long- Term Complications of Type II Diabetes Mellitus
DOI:
https://doi.org/10.48165/n5eeya77Keywords:
Diabetic foot, retinopathy, neuropathy, hypertensionAbstract
Background: The aim is to assess long term complications of type II diabetes mellitus. Subjects and Methods : One hundred twenty- six adult subjects in age range 20-60 years of either gender diagnosed with type II diabetes mellitus were selected. 5 ml of venous blood was obtained and all were subjected to fasting blood glucose, random blood glucose and glycated hemoglobin assessment. History of diet, smoking, alcoholism was obtained. Complications occurring in subjects was recorded in case history proforma. Results: Out of 126 subjects, males were 76 (60.3%) and females were 50 (39.6%). Common risk factors recorded were obesity seen in 68, alcohol in 53 and smoking in 48. The difference was non significant (P> 0.05). Common long- term complications were retinopathy seen in 72, neuropathy in 30, nephropathy in 48, hypertension in 97, diabetic foot in 56 and impotency in 32 patients. The difference was significant (P< 0.05). Conclusion: Common long- term complications were retinopathy, neuropathy, nephropathy, hypertension, diabetic foot and impotency.
Background: The aim is to assess long term complications of type II diabetes mellitus. Subjects and Methods : One hundred twenty- six adult subjects in age range 20-60 years of either gender diagnosed with type II diabetes mellitus were selected. 5 ml of venous blood was obtained and all were subjected to fasting blood glucose, random blood glucose and glycated hemoglobin assessment. History of diet, smoking, alcoholism was obtained. Complications occurring in subjects was recorded in case history proforma. Results: Out of 126 subjects, males were 76 (60.3%) and females were 50 (39.6%). Common risk factors recorded were obesity seen in 68, alcohol in 53 and smoking in 48. The difference was non significant (P> 0.05). Common long- term complications were retinopathy seen in 72, neuropathy in 30, nephropathy in 48, hypertension in 97, diabetic foot in 56 and impotency in 32 patients. The difference was significant (P< 0.05). Conclusion: Common long- term complications were retinopathy, neuropathy, nephropathy, hypertension, diabetic foot and impotency.
Background: The aim is to assess long term complications of type II diabetes mellitus. Subjects and Methods : One hundred twenty- six adult subjects in age range 20-60 years of either gender diagnosed with type II diabetes mellitus were selected. 5 ml of venous blood was obtained and all were subjected to fasting blood glucose, random blood glucose and glycated hemoglobin assessment. History of diet, smoking, alcoholism was obtained. Complications occurring in subjects was recorded in case history proforma. Results: Out of 126 subjects, males were 76 (60.3%) and females were 50 (39.6%). Common risk factors recorded were obesity seen in 68, alcohol in 53 and smoking in 48. The difference was non significant (P> 0.05). Common long- term complications were retinopathy seen in 72, neuropathy in 30, nephropathy in 48, hypertension in 97, diabetic foot in 56 and impotency in 32 patients. The difference was significant (P< 0.05). Conclusion: Common long- term complications were retinopathy, neuropathy, nephropathy, hypertension, diabetic foot and impotency.
Background: The aim is to assess long term complications of type II diabetes mellitus. Subjects and Methods : One hundred twenty- six adult subjects in age range 20-60 years of either gender diagnosed with type II diabetes mellitus were selected. 5 ml of venous blood was obtained and all were subjected to fasting blood glucose, random blood glucose and glycated hemoglobin assessment. History of diet, smoking, alcoholism was obtained. Complications occurring in subjects was recorded in case history proforma. Results: Out of 126 subjects, males were 76 (60.3%) and females were 50 (39.6%). Common risk factors recorded were obesity seen in 68, alcohol in 53 and smoking in 48. The difference was non significant (P> 0.05). Common long- term complications were retinopathy seen in 72, neuropathy in 30, nephropathy in 48, hypertension in 97, diabetic foot in 56 and impotency in 32 patients. The difference was significant (P< 0.05). Conclusion: Common long- term complications were retinopathy, neuropathy, nephropathy, hypertension, diabetic foot and impotency.
Background: The aim is to assess long term complications of type II diabetes mellitus. Subjects and Methods : One hundred twenty- six adult subjects in age range 20-60 years of either gender diagnosed with type II diabetes mellitus were selected. 5 ml of venous blood was obtained and all were subjected to fasting blood glucose, random blood glucose and glycated hemoglobin assessment. History of diet, smoking, alcoholism was obtained. Complications occurring in subjects was recorded in case history proforma. Results: Out of 126 subjects, males were 76 (60.3%) and females were 50 (39.6%). Common risk factors recorded were obesity seen in 68, alcohol in 53 and smoking in 48. The difference was non significant (P> 0.05). Common long- term complications were retinopathy seen in 72, neuropathy in 30, nephropathy in 48, hypertension in 97, diabetic foot in 56 and impotency in 32 patients. The difference was significant (P< 0.05). Conclusion: Common long- term complications were retinopathy, neuropathy, nephropathy, hypertension, diabetic foot and impotency.
References
1. Kostev K, Jockwig A, Hallwachs A. Prevalence and risk factors of neuropathy in newly diagnosed type 2 diabetes in primary care practices: a retrospective database analysis in Germany. Prim Care Diabetes. 2014;8(3):250–255. Available from: https: //doi.org/10.1016/j.pcd.2014.01.011.
2. Piniés JA, González-Carril F, Arteagoitia JM. Development of a prediction model for fatal and non-fatal coronary heart disease and cardiovascular disease in patients with newly diagnosed type 2 diabetes mellitus: the Basque country prospective complications and mortality study risk engine (BASCORE). Diabetologia. 2014;57(11):2324–2333. Available from: https: //doi.org/10.1007/s00125-014-3370-1.
3. Sandbæk A, Griffin SJ, Sharp SJ, Simmons RK, Borch-Johnsen K, Rutten GEHM, et al. Effect of early multifactorial therapy compared with routine care on microvascular outcomes at 5 years in people with screen-detected diabetes: a randomized controlled trial: the ADDITION-Europe study. Diabetes Care. 2014;37(7):2015–2023. Available from: https://doi.org/10. 2337/dc13-1544.
4. Martinell M, Dorkhan M, Stålhammar J, Storm P, Groop L, Gustavsson C. Prevalence and risk factors for diabetic retinopathy at diagnosis (DRAD) in patients recently diagnosed with type 2 diabetes (T2D) or latent autoimmune diabetes in the adult (LADA). J Diabetes Complications. 2016;30(8):1456– 1461. Available from: https://doi.org/10.1016/j.jdiacomp. 2016.08.009.
5. Boulton J, Kempler P, Ametov A, Ziegler D. Whether pathogenetic treatments for diabetic polyneuropathy? Diabetes Metab Res Rev. 2013;29(5):327–333. Available from: https: //doi.org/10.1002/dmrr.2397.
6. Vincent AM, Callaghan BC, Smith AL, Feldman EL. Diabetic neuropathy: cellular mechanisms as therapeutic targets. Nat Rev Neurol. 2011;7(10):573–583. Available from: https://doi. org/10.1038/nrneurol.2011.137.
7. Guariguata L. By the numbers: new estimates from the IDF Diabetes Atlas Update for 2012. Diabetes Res Clin Pract. 2012;98(3):524–525. Available from: https://doi.org/10.1016/ j.diabres.2012.11.006.
8. Chawla A, Chawla R, Jaggi S. Microvasular and macrovascular complications in diabetes mellitus: Distinct or continuum? Indian J Endocrinol Metab. 2016;20(4):546–551. Available from: https://dx.doi.org/10.4103/2230-8210.183480.
9. Mohan V, Pradeepa R. Epidemiology of diabetes in different regions of India. Health Administrator. 2009;22:1–18. 10. Rani PK, Raman R, Rachapalli SR, Pal SS, Kulothungan V, Sharma T. Prevalence and risk factors for severity of diabetic neuropathy in type 2 diabetes mellitus. Indian J Med Sci. 2010;64(2):51–57.
11. Oguejiofor OC, Odenigbo CU, Oguejiofor CB. Evaluation of the effect of duration of diabetes mellitus on peripheral neuropathy using the United Kingdom screening test scoring system, bio-thesiometry and aesthesiometry. Niger J Clin Pract. 2010;13(3):240–247.
12. Escobar C, Blanes I, Ruiz A, Vinuesa D, Montero M, Rodríguez M. Prevalence and clinical profile and management of peripheral arterial disease in elderly patients with diabetes. Eur J Intern Med. 2011;22(3):275–281. Available from: https: //doi.org/10.1016/j.ejim.2011.02.001.
13. Banoo S, Shubha DS, Shashidhar V, Venkatesha D. Bacterial and clinical profile of diabetic foot patients. Ann Trop Med Public Health. 2012;5(2):69–73. Available from: http://dx.doi. org/10.4103/1755-6783.95952.
14. Bonora E, Trombetta M, Dauriz M, Travia D, Cacciatori V, Brangani C, et al. Chronic complications in patients with newly diagnosed type 2 diabetes: prevalence and related metabolic and clinical features: the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 9. BMJ Open Diab Res Care. 2020;8(1):1549. Available from: https://doi.org/10.1136/bmjdrc-2020-001549.
15. Jelinek HF, Osman WM, Khandoker AH, Khalaf K, Lee S, Almahmeed W, et al. Clinical profiles, comorbidities and complications of type 2 diabetes mellitus in patients from United Arab Emirates. BMJ Open Diabetes Res Care. 2017;5(1):427. Available from: https://doi.org/10.1136/ bmjdrc-2017-000427.
16. Katulanda P, Ranasinghe P, Jayawardena R, Constantine GR, Sheriff M, Matthews DR. The prevalence, patterns and
predictors of diabetic peripheral neuropathy in a developing country. Diabetol Metab Syndr. 2012;4(1):21. Available from: https://doi.org/10.1186/1758-5996-4-21.
17. Sriwijitkamol A, Moungngern Y, Vannaseang S. Assessment and prevalences of diabetic complications in 722 Thai type 2 diabetes patients. J Med Assoc Thai. 2011;94(2):168–174.
